Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ALKS stock price vs WEX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WEX's multiple
Needs WEX P/E.
Implied fair value · at ALKS's multiple
Needs ALKS P/E.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALKS FY 2025 (ended Dec 31, 2025) · WEX FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Alkermes plc. · implied price per share
Bear
$16.05
Base
$18.89
Bull
$21.72
WEX Inc. · implied price per share
Bear
$306.35
Base
$360.41
Bull
$414.47
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.16x
3.94x
Net debt / EBITDA
Leverage against operating earnings
-0.80x
-0.28x
Cash and equivalents
Liquid reserves on the balance sheet
$587.34M
$5.24B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Jazz Pharmaceuticals plc
ALKS vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
ALKS vs SUPN
Amneal Pharmaceuticals, Inc.
ALKS vs AMRX
GLOBAL PAYMENTS INC
ALKS vs GPN
Shift4 Payments, Inc.
ALKS vs FOUR
JACK HENRY & ASSOCIATES INC
ALKS vs JKHY
PAYCHEX INC
ALKS vs PAYX
AUTOMATIC DATA PROCESSING INC
ALKS vs ADP
CORPAY, INC.
ALKS vs CPAY
$290.73M
$4.86B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
